Anti-AIFM2 (111-123) antibody produced in rabbit

IgG fraction of antiserum, buffered aqueous solution

Anti-AMID, Anti-PRG3, Anti-AIFM2 Isoform 1 of Apoptosis-inducing factor 2
Pricing and availability is not currently available.

biological source


antibody form

IgG fraction of antiserum

antibody product type

primary antibodies




buffered aqueous solution

mol wt

antigen ~41 kDa

species reactivity



western blot: 1:500-1:2,000



UniProt accession no.

shipped in

dry ice

storage temp.


Gene Information

human ... AIFM2(84883)

General description

Rabbit Anti-AIFM2 (111-123) antibody binds to human AIFM2 (111-123).
AIFM2 induces p53-dependent apoptosis by binding to single stranded DNA in the presence of bacterial of viral DNA.


synthetic peptide corresponding to amino acids 111-123 of human AIFM2


Yale Center for High Throughput Cell Biology IF-tested antibodies. Each antibody is tested by immunofluorescence against HUVEC cells using the Yale HTCB IF protocol. To learn more about us and Yale Center for High Throughput Cell Biology partnership, visit sigma.com/htcb-if.
Rabbit Anti-AIFM2 (111-123) antibody can be used for western blot assays at dilutions ranging from 1:500 to 1:2,000.

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide

Personal Protective Equipment

dust mask type N95 (US),Eyeshields,Gloves


NONH for all modes of transport

WGK Germany


The human apoptosis-inducing protein AMID is an oxidoreductase with a modified flavin cofactor and DNA binding activity.
Marshall, KR.
The Journal of Biological Chemistry, 280, 30740-30735 (2005)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.